This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industry The acquired portfolio comprises the core ...
LOS ANGELES, Feb. 27, 2020 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), a global scientific authority on nicotinamide adenine dinucleotide (NAD) and nicotinamide riboside (NR) science, announced ...
The gold standard in NAD+ supplementation, Niagen ® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement LOS ANGELES, November 14, ...
In the first controlled clinical trial of nicotinamide riboside (NR), a newly discovered form of Vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell ...
This study, which utilized the gold standard method of stable isotopes, reinforces that NMN cannot cross the cell membrane directly and must first be converted to NR LOS ANGELES--(BUSINESS ...
This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industry LOS ...
This acquisition establishes Niagen Bioscience (NAGE) as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industry LOS ANGELES--(BUSINESS WIRE)-- ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has acquired a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback